Evidence map›Paper›PMID 41063886›Full record

ReviewCureus2025

Management of Patients With Opioid Use Disorder (OUD).

Nathan Martin-Orr, Steve Yun

Abstract readReview
In one paragraph

Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Nathan Martin-OrrAnesthesia, University of California Irvine Medical Center, Orange, USA.
Steve YunAnesthesia, Western University of Health Sciences, Pomona, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Managing patients with opioid use disorder (OUD) presents a critical challenge in the perioperative setting. Due to challenges like opioid-induced hyperalgesia (OIH), withdrawal and relapse risks, and altered opioid pharmacodynamics, traditional pain management strategies may be inadequate or even counterproductive. Despite the inconsistency in clinical guidelines and variation in perioperative protocols for OUD patients, mounting evidence indicates that effective analgesia techniques do exist, such as multimodal analgesia, regional anesthesia, opioid agonist therapy (OAT), and non-opioid adjuncts. Evidence suggests that continuing OAT (methadone or buprenorphine) during the perioperative period may improve pain control and reduce relapse risk. Multimodal analgesia techniques decrease opioid usage while increasing pain relief. This review will highlight literature that demonstrates the effectiveness and benefit of these treatments for OUD patients. The complexity of OUD and its impact on perioperative care requires a patient-centered, multidisciplinary approach in order to increase safety and optimize patient outcomes. This review demonstrates the need to address research gaps, reduce the negative stigma surrounding this disorder, and establish standardized clinical guidelines that prioritize multimodal pain management and inclusive OUD treatment strategies.

Indexed as

buprenorphinemethadonemultimodal analgesiaopioid-agonist therapyopioid-induced hyperalgesiaopioid use disorderperioperative pain managementregional anesthesia

Identifiers

PMID41063886
PMCPMC12503585

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.